Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance

BACKGROUND: Many men diagnosed with prostate cancer are active surveillance (AS) candidates. However, AS may be associated with increased risk of disease progression and metastasis due to delayed therapy. Genomic classifiers, e.g., Decipher, may allow better risk-stratify newly diagnosed prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung L., Li, Ping, Huang, Huei-Chung, Deheshi, Samineh, Marti, Tara, Knudsen, Beatrice, Abou-Ouf, Hatem, Alam, Ridwan, Lotan, Tamara L., Lam, Lucia L. C., du Plessis, Marguerite, Davicioni, Elai, Fleshner, Neil, Lane, Brian R., Ross, Ashley E., Davis, John W., Mohler, James L., Trock, Bruce J., Klein, Eric A., Tosoian, Jeffrey J., Hyndman, M. Eric, Bismar, Tarek A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760567/
https://www.ncbi.nlm.nih.gov/pubmed/30542054
http://dx.doi.org/10.1038/s41391-018-0101-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760567/
https://www.ncbi.nlm.nih.gov/pubmed/30542054
http://dx.doi.org/10.1038/s41391-018-0101-6

Ejemplares similares